Send Inquiry

Request To Call Back

Doxofylline WHO GMP

Name: Doxofylline WHO GMP
Brand: NR LIFE CARE
Price: 1 INR
Availability: InStock

Price 1 INR/ Kilograms

Get a Price/Quote

MOQ : 100 Kilograms

Doxofylline WHO GMP Specification

Molecular Formula
C11H14N4O4

Storage
Store in a cool, dry place, protected from light and moisture

Properties
Bronchodilator; Xanthine derivative; Non-caffeine pharmacology; Used in respiratory therapy

Melting Point
215C - 217C

Solubility
Soluble in water, slightly soluble in ethanol

EINECS No
274-802-6

Smell
Odorless

Shape
Crystalline

Structural Formula
Available on request

Taste
Slightly bitter

Usage
For formulation of tablets and syrups for respiratory indications

Purity
99%

HS Code
2939

Application
Used in the management of asthma and chronic obstructive pulmonary disease (COPD)

Appearance
White crystalline powder

Grade
Pharmaceutical Grade

Density
1.4 Gram per cubic centimeter(g/cm3)

Molecular Weight
266.25 g/mol

Ph Level
Neutral

CAS No
69975-86-6

Physical Form
Powder

Shelf Life
36 months

Product Type
Active Pharmaceutical Ingredient

Ingredients
Doxofylline

End Use
Pharmaceutical formulations (oral dosage forms)

Identification
Confirms by IR & HPLC

Standard Certification
WHO GMP certified

Manufacturing Compliance
Complies with International Pharmacopoeia

Loss on Drying
0.5%

Stability
Stable at room temperature when protected from moisture

Packaging Type
Sealed double LDPE bags in HDPE drums of 25 kg net

Microbial Limits
As per IP/BP/USP

Therapeutic Category
Respiratory drug, bronchodilator

Related Substances
Total impurities 0.5%

Heavy Metals
10 ppm

Residue on Ignition
0.1%

Doxofylline WHO GMP Trade Information

Minimum Order Quantity
100 Kilograms

FOB Port
mudara

Payment Terms
Cash in Advance (CID), Letter of Credit at Sight (Sight L/C), Letter of Credit (L/C)

Supply Ability
1000 Kilograms Per Month

Delivery Time
7 Days

Sample Available
Yes

Sample Policy
Contact us for information regarding our sample policy

Main Export Market(s)
Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

Main Domestic Market
All India, South India, Central India, West India, North India, East India, Gujarat, Karnataka, Kerala, Lakshadweep, Mizoram, Meghalaya, Manipur, Andhra Pradesh, Bihar, Chandigarh, Daman and Diu, Goa, Jharkhand, Odisha, Punjab, Assam, Delhi, Dadra and Nagar Haveli, Andaman and Nicobar Islands, Arunachal Pradesh, Chhattisgarh, Haryana, Himachal Pradesh, Jammu and Kashmir, Madhya Pradesh, Maharashtra, Nagaland, Rajasthan, Sikkim, Tamil Nadu, Telangana, Tripura

About Doxofylline WHO GMP

Doxofylline WHO GMP is an acclaimed, highly recommended bronchodilator recognized for its stellar efficacy in respiratory care. This distinguished pharmaceutical-grade compound, widely accessed by professionals, is manufactured under strict WHO GMP standards and surpasses international pharmacopoeia requirements. Presented as a brilliant white crystalline powder, it boasts superior purity (99%) and stability, making it ideal for tablets and syrups. Its non-poisonous, odorless profile-combined with low impurity levels-ensures safe formulation for asthma and COPD management. Available in sealed LDPE bags within HDPE drums (25kg), it is highly suitable for distributors, exporters, and manufacturers worldwide.

Versatile Application & Distinguished Features

Doxofylline WHO GMP showcases its excellence across a wide area of respiratory applications, especially in the treatment of asthma and chronic obstructive pulmonary disease (COPD). Perfect for oral dosage forms such as tablets and syrups, this pharmaceutical-grade substance features a neutral pH, is highly soluble in water, and stable at room temperature. Its non-caffeine xanthine derivative nature and stellar safety profile make it a brilliant choice for varied therapeutic and formulation requirements.

Sample, Delivery, and Export Excellence

Samples of Doxofylline WHO GMP are accessible for evaluation with prompt quotation. The product is available for quick dispatch, ensuring rapid delivery to clients both in India and on major export markets globally. Flexible payment terms are provided, catering to distributors, wholesalers, importers, and suppliers. Our commitment to efficient logistics and comprehensive service guarantees a smooth, timely experience for buyers seeking renowned respiratory therapy ingredients.

FAQ's of Doxofylline WHO GMP:

Q: How does Doxofylline benefit patients with asthma and COPD?

A: Doxofylline acts as a bronchodilator, relaxing respiratory muscles to improve airflow and ease breathing in patients suffering from asthma and chronic obstructive pulmonary disease (COPD).

Q: What are the main applications of Doxofylline WHO GMP?

A: This product is primarily used in pharmaceutical formulations like tablets and syrups intended for respiratory therapy, particularly in the management of asthma and COPD.

Q: Where is Doxofylline WHO GMP manufactured and what certifications does it hold?

A: Doxofylline WHO GMP is manufactured in India and meets stringent WHO GMP and International Pharmacopoeia standards, ensuring high quality and compliance.

Q: How is Doxofylline WHO GMP packaged for shipment?

A: The product is securely packed in double LDPE bags contained within HDPE drums, each with a net weight of 25 kg, ensuring product integrity during transport.

Q: What process ensures the purity and compliance of Doxofylline WHO GMP?

A: Each batch is validated by IR & HPLC identification methods and tested for loss on drying, heavy metals, and impurities, guaranteeing 99% purity and compliance with IP/BP/USP microbial limits.

Tell us about your requirement